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AIMS
The aim of this study was firstly to reveal the determinants of GP prescribing behaviour for older adults in primary care and
secondly to elicit GPs’ views on the potential role for broad intervention strategies involving pharmacists and/or information
technology systems in general practice.
METHODS
Semi-structured qualitative interviews were carried out with a purposive sample of GPs. Three multidisciplinary researchers
independently coded the interview data using a framework approach. Emerging themes were mapped to the Theoretical
Domains Framework (TDF), a tool used to apply behaviour change theories.
RESULTS
Sixteen GPs participated in the study. The following domains in the TDF were identified as being important determinants of GP
prescribing behaviour: ‘Knowledge’, ‘Skills’, ‘Reinforcement’, ‘Memory Attention and Decision Process’, ‘Environmental Context
and Resources’, ‘Social Influences’, ‘Social/Professional Role and Identity’. Participants reported that the challenges associated
with prescribing for an increasingly older population will require them to become more knowledgeable in pharmacology and
drug interactions and they called for extra training in these topics. GPs viewed strategies such as academic detailing sessions
delivered by pharmacists or information technology systems as having a positive role to play in optimizing prescribing.
CONCLUSION
This study highlights the complexities of behavioural determinants of prescribing for older people in primary care and the need for
additional supports to optimize prescribing for this growing cohort of patients. Interventions that incorporate, but are not limited
to interprofessional collaboration with pharmacists and information technology systems, were identified by GPs as being
potentially useful for improving prescribing behaviour, and therefore require further exploration.
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WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT
• Providing optimal medication management for older people is a challenge for GPs.
• Prescribing for older people can result in medication-related problems and preventable drug-related morbidity.
• As the main prescribers of medication in primary care, GPs can provide a deeper insight into the complexities of
prescribing for these patients.
WHAT THIS STUDY ADDS
• Prescribing for the growing older population is viewed by GPs as a significant challenge in their clinical practice.
• GPs are calling for additional support in order to help them manage and treat these patients.
• Academic detailing, an approach that provides GPs with accurate, non-biased and evidence-based information, is viewed
by GPs as a potentially useful way to help optimize their prescribing. Information technology systems are also identified
by GPs as having a role to play in supporting safer prescribing.
Introduction
Providing optimal care for older adults creates many chal-
lenges for healthcare providers, especially general practi-
tioners (GPs) [1–4]. Appropriate prescribing of medications
is a significant challenge as older adults can present with
multiple conditions for whichmultiple medications are often
indicated [5, 6]. Age-related changes in pharmacokinetics
and pharmacodynamics contribute to the challenge of
appropriate prescribing [7]. Inappropriate prescribing results
in preventable drug-related morbidity (PDRM), including ad-
verse drug events (ADEs), hospital admissions and mortality
[8–10]. Potential PDRM events occur in 1% of patients
attending general practice, with the most common PDRM
events relating to the use of non-steroidal anti-inflammatory
(NSAID) medicines in patients with congestive heart failure
or hypertension, lack of monitoring in patients prescribed
angiotensin converting enzyme (ACE) inhibitors, and the
use of hypnotic-anxiolytic agents [11].
As GPs are the main prescribers of medication in primary
care, understanding the factors influencing GP behaviour in
relation to prescribing is a first step in reducing PDRM and
improving clinical outcomes [12]. Previous research has
shown that factors influencing GP prescribing decisions in-
clude medication effectiveness, associated risks, medication
costs and patient characteristics or preferences [13]. Other in-
fluences include factors which relate specifically to the indi-
vidual GP such as postgraduate qualifications or training
[14], the prescribing behaviour of hospital consultants [15],
or advertising by the pharmaceutical industry [16]. However,
how best to intervene on these influences to improve GP pre-
scribing is not known. It has been proposed that knowledge
of the key determinants of health care professionals’ (HCP)
behaviour can be used to theoretically inform interventions
that aim to change that behaviour [17]. Additionally, qualita-
tive research with HCPs can inform and optimize the delivery
of subsequent interventions.
The Theoretical Domains Framework (TDF) is an
overarching framework of theories that identifies the specific
process underlying successful behaviour change [18]. It
consists of 14 domains and 84 component constructs [19].
The TDF has been used to identify key theoretical domains
that are perceived to influence HCPs’ behaviours [19]. For
example, Cullinan et al. used the TDF to identify key
influences of potentially inappropriate prescribing (PIP) by
hospital doctors such as insufficient training in prescribing
for older people [20].
The aim of this study was firstly to reveal the determi-
nants of GP prescribing behaviour for older adults in primary
care and secondly to elicit GPs’ views on the potential role for
broad intervention strategies, e.g. involving pharmacists
and/or information technology systems in general practice.
Participants were also encouraged to suggest any other types
of intervention that they thought would be feasible and
useful.
Methods
Design
Semi-structured qualitative interviews were conducted with
GPs in primary care to explore their experiences of prescrib-
ing for patients aged over 65 years and their views on the po-
tential role for interventions involving pharmacists and/or
information technology systems in general practice. This in-
terview method was chosen due to its flexible and interactive
nature and its ability to achieve comprehensive coverage of
the topic discussed [21]. The descriptions of their experiences
were analysed using qualitative methods and mapped to the
TDF framework to reveal behavioural determinants.
Sampling
This study was conducted in County Cork, Republic of
Ireland. A purposive sample of GPs in teaching practices asso-
ciated with University College Cork (UCC) were initially in-
vited to participate. The purposive sampling strategy was
based on years of experience (>10 or <10 years), practice lo-
cation (% urban population of GP practice location) and prac-
tice size (single or group practice). There were no inclusion or
exclusion criteria for participants other than a requirement to
be in active clinical practice. D.O.R. contacted potential
participants by telephone and a brief summary of the study
was given. In some cases, snowball sampling was used when
participants who were based in single rural practices and
had already been interviewed were asked to identify other
GPs whom they thought might be interested in participating.
The nominated GPs were then sampled according to the
needs of the sampling frame.
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Two pilot interviews were conducted. Following review of
the data and topic guides, the authors agreed to include the
data generated from the pilot interviews as it was highly rele-
vant to the study question.
The method developed by Francis et al. was used to deter-
mine data saturation [22]. Firstly, the authors agreed a priori
that the first 10 participants (initial analysis sample) repre-
sented adequate diversity on the pre-specified stratification
factors (years of experience, gender, practice location and
practice size). Secondly, it was agreed a priori that after 10 in-
terviews were conducted, data saturation was reached once
three consecutive interviews did not contribute further to
thematic development (stopping criterion). The stopping cri-
terion was tested after each successive interview, e.g. 11, 12,
13. At interview 13, a further three interviews were carried
out to identify new themes. However, these additional inter-
views did not contribute to the further development of
emerging themes. Therefore, interview 16 was defined as the
point of data saturation.
Data collection
The interviews were carried out by one researcher (D.O.R.) at
the GP surgeries between March 2015 and August 2015.
A topic guide was developed based on previous literature
and was agreed on by all authors [23, 24]. It was iteratively re-
fined after each interview was transcribed and analysed to
pursue emerging themes. Further refinements were reviewed
by another author (C.S.) and examples are provided as
supplementary material (see Appendix S1) to show its
continuous development as the interviews proceeded.
Demographic details were collected including practice loca-
tion, GP gender, years’ experience as a GP and number of
GPs, including GP registrars where relevant, working in
the practice. In addition to questions on their experience
of prescribing for older patients, participants were asked
for their views on the potential role for interventions
(i.e. involving pharmacists and/or information technology
systems) in general practice.
The interviews were audio-recorded, fully transcribed and
saved in NVivo Qualitative Data Analysis Software (V.10.22)
to facilitate analysis (QSR International, Doncaster, Vic.,
Australia. Field notes were written and used to facilitate pre-
liminary familiarization with emerging themes immediately
after each interview.
Analysis
The framework approach, which consists of five stages, was
used to analyse the data [21]. The first phase involved reading
and re-reading each transcript as well as listening to interview
recordings to become familiar with the content. The second
phase involved identifying a thematic framework. Due to
the specifics of the research aim, a deductive approach was
taken with agreement a priori by the authors to use the Theo-
retical Domains Framework (TDF). The next phase was
indexing: this involved open coding (carried out by D.O.R.)
and development of a coding scheme. The fourth phase in-
volved arranging data into domains of the TDF and generat-
ing charts. The last phase involved interpreting the data by
finding associations between themes with the aim of provid-
ing explanations for them. To enhance the credibility of
coding, three multidisciplinary researchers (D.O.R., C.S. and
S.B.) independently coded a sample of the transcripts.
The consolidated criteria for reporting qualitative re-
search (COREQ) statement was used to guide reporting of
the findings (see Appendix S2) [25].
Ethical approval for this study was granted by the clinical
research ethics committee of the Cork University Teaching
Hospitals (reference ECM 3 (mmm) 14/04/15 & 4 (k) 07/10/
14). All participants provided written informed consent.
Results
Sixteen interviews were conducted in total. The interviews
ranged from 9 min to 31 min (mean interview length
19 min). The mean duration of participating GPs’medical ex-
perience was 17 years. The number of GPs working in a prac-
tice ranged from 1 to 6. The characteristics of participants
interviewed are provided in Table 1.
The definition of all 14 TDF domains as described by Cane
et al. together with supporting quotes from participants are
shown in Table 2 [19].
Almost all of the TDF domains were seen to be relevant
to the study data but the domains presented in detail here
were prioritized because of the emphasis placed on them
by participants, the frequency of occurrence of the domain
across all the transcripts, and the consensus agreement of
the authors.
Important influences on GP prescribing
behaviour identified using the TDF
Knowledge/Skills. Although they are described separately in
the TDF, it was decided to merge the domains ‘Knowledge’
and ‘Skills’ as the findings that emerged were overlapping
and therefore are reported as a single domain.
Participants reported the responsibility of prescribing for
increasing numbers of complicated older patients as a bur-
den. They voiced that they felt this would become even more
demanding in the future. Participants reported a need to be-
come more knowledgeable in pharmacology and drug inter-
actions and they called for extra training in order to manage
and treat these patients.
‘… it’s going to have a huge impact on general practice and
GPs, I think we’ll need to try and continue to improve our skills
in that area and I think… care of the elderly… will be a speci-
ality … it’s going to present a lot of challenges in terms of
knowing the pharmacology and interactions.’ (GP11)
Participants acknowledged the importance of their role as
prescribers and suggested regular evaluation of their prescrib-
ing knowledge would motivate GPs to stay up-to-date with
their prescribing skills and in some cases change the way they
practise or enhance the care of their patients.
‘I personally think that we should have to every 6 or 12 months
sit some kind of exam in prescribing… because prescribing is so
desperately important and I think the only way I would
actually change the way I practise is if there was some kind of
revalidation.’ (GP15)
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Participants reported that they are influenced by informa-
tion provided by pharmaceutical drug representatives despite
viewing this information as biased. They called for alternative
sources of succinct information that can be delivered in their
practices, but is independent of the pharmaceutical industry
and is evidence-based.
‘Three times a week for 5 minutes I meet a drug rep… so while
we take it with a pinch of salt, because we know it’s biased …
we inevitably are influenced by drug reps.’ (GP15)
Reinforcement. Participants viewed prescribing in older
people as a potential source of litigation should a
prescribing error arise. They reported that the risk of error is
higher in these patients due to the medical complexity and
the possible interactions and side effects associated with the
use of multiple medicines. The fear of litigation made some
GPs more cautious and acted as an incentive to optimize
their prescribing for these patients.
‘I’m pretty sure it’s out there somewhere that it’s the biggest
source of litigation I think for GPs is prescribing or … prescrib-
ing errors.’ (GP13)
Memory attention and decision process
Participants actively considered various factors when pre-
scribing medicines, e.g. when to start them, when to stop
them, their side-effects, their potential for addiction, their
potential adverse outcomes. The decision-making process
can become more complicated when a patient is already pre-
scribed multiple medicines. This was mentioned as a
particular issue when considering medicines with potential
adverse effects, as they can lead to a prescribing cascade.
‘If you do need to use something … bearing in mind their car-
diovascular risk, bearing in mind their falls risk that go with
lots of the sedative medication, antipsychotics, sleeping tablets
… I think that’s my biggest bugbear, difficulty.’ (GP13)
Some participants were reluctant to prescribe poten-
tially useful medicines such as methotrexate out of fear
of their side-effects in older, more vulnerable patients. It
was also evident that there was a level of caution and un-
certainty around the prescribing of these high-risk
medicines.
‘But if it was something like methotrexate … even thinking
about it now would give you the heebee jeebees… you’ve some-
body elderly in front of you and you’re really not sure, I just
don’t think you can prescribe it really you know.’ (GP11)
Environmental context and resources
Although prescribing was seen as an important responsibility
by participants, they did not always get time to review medi-
cations as thoroughly as they would like.
‘If you’re really busy sometimes and I’m just being honest, you
just print off their last month’s prescription and you’ll keep go-
ing with that, you know.’ (GP4)
Pharmacists were described as a useful resource for GPs es-
pecially in cases where older patients were having
Table 1
Characteristics of GP participants
General
Practitioner (GP) Gender
Years of medical
experience
% urban population
of GP practice location
No. of GPs in
the practice
No. of GP registrars
in the practice
1 F 4 19.5 2 0
2 F 20 25.7 4 1
3 M 33 25.7 4 1
4 F 20 25.7 1 0
5 F 4 100 2 0
6 M 25 25.7 4 1
7 F 4 8.4 2 0
8 M 20 100 2 0
9 M 35 25.7 4 1
10 F 19 25.7 1 0
11 F 13 100 3 1
12 F 4 25.7 4 1
13 M 3 19.5 2 0
14 M 30 100 3 1
15 M 14 8.8 6 0
16 M 27 25.7 4 1
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Table 2
TDF domains, explanatory constructs and supporting quotes [19]
Domain (definition) and constructs
Domain reported in
the study results Supporting quotes
1. Knowledge (an awareness of the existence of something)
Constructs
• Knowledge (including knowledge of condition/scientific rationale)
• Procedural knowledge
• Knowledge of task environment
✓ ‘… It’s going to have a huge impact on general
practice and GPs, I think we’ll need to try and
continue to improve our skills in that area and I
think care of the elderly… will be a speciality… it’s
going to present a lot of challenges in terms of
knowing the pharmacology and interactions.’
(GP11)
‘Three times a week for 5 minutes I meet a drug rep
… so while we take it with a pinch of salt, because
we know it’s biased… we inevitably are influenced
by drug reps …’ (GP15)
2. Skills (an ability or proficiency acquired through practice)
Constructs
• Skills/Skills development
• Competence
• Ability
• Interpersonal skills
• Practice
• Skill assessment
✓ ‘I personally think that we should have to every 6
or 12 months sit some kind of exam in prescribing
… because prescribing is so desperately important
and I think the only way I would actually change
the way I practise is if there was some kind of
revalidation.’ (GP15)
‘We find that in General Practice there are so many
important areas we need to up skill in. And this is a
particularly important one (Educational training),
and I think you’d probably find that most GPs
would agree with that.’ (GP5)
3. Social/Professional Role and Identity (a coherent set of behaviours
and displayed personal qualities of an individual in a social or work
setting)
Constructs
• Professional identity/ Social identity
• Professional role
• Identity/Group identity
• Professional boundaries
• Professional confidence
• Leadership
• Organizational commitment
✓ ‘I think some of the hospital sector, don’t fully
understand the nature of general practice … I saw
a person with a renal problem and I was in their
house … I rang the Urology (team) because they
had a nephrostomy tube and they were asking me
what his creatinine was… they just had no idea
that you don’t have a portable creatinine monitor
by your side.’ (GP8)
‘As a GP you have a role as a co-ordinator of care,
and you’d have the most up to date record of
everything that’s going on.’ (GP5)
4. Beliefs about Capabilities (acceptance of the truth, reality, or validity
about an ability, talent or facility that a person can put to constructive
use)
Constructs
• Self-confidence
• Perceived competence
• Self-efficacy
• Perceived behavioural control
• Beliefs
• Self-esteem
• Empowerment
• Professional confidence
X ‘I am slow to start new medications for 6 to 12
months I leave it out on the market and I think
sometimes other professionals … may not think of
that in a positive way but that’s the way I am.’
(GP16)
‘Sometimes there’s this feeling going around
unless you are using the new medications you are
sometimes behind the times or a bit old fashioned
… but sometimes it might be that there’s much
better evidence for the older medication or you
know it’s been studied a lot more and there might
be very little evidence for the new one and the new
one might be 5–6 times the cost if not more.’ (GP8)
5. Optimism (the confidence that things will happen for the best or that
desired goals will be attained)
Constructs
• Optimism
• Pessimism
• Unrealistic optimism
• Identity
X ‘We need enhanced roles of the … pharmacists,
the practice nurses, advanced nurse practitioners,
more community nurse workers as well as public
health nurses you know such as dementia care
nurses and things like that. I think all those things
will sort of help give a better standard. I think it will
happen bit by bit.’ (GP8)
‘There needs to be a common goal that the patient
is a priority and it is very significantly absent from
management and health services. Ok, they do not
look at the patient goal because the managers
regard the management as being totally isolated
from health responsibility. With any luck we’ll
bring that around.’ (GP3)
(continues)
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Table 2
(Continued)
Domain (definition) and constructs
Domain reported in
the study results Supporting quotes
6. Beliefs about Consequences
(acceptance of the truth, reality, or validity about outcomes of a
behaviour in a given situation)
Constructs
• Beliefs
• Outcome expectancies
• Characteristics of outcome expectancies
• Anticipated regret
• Consequents
X ‘One issue that springs to mind is …
benzodiazepine prescribing, so you would have a
cohort of elderly patients who have been prescribed
benzodiazepines for a very long period of time,
that you wouldn’t be in a position to be really
thinking about stopping them, but certainly you
would wonder if, certain events such as a fall, an
episode of confusion, could be related to these
particular medications.’ (GP5)
‘One of the biggest problems at the moment is the
generic substitution, it is confusing the hell out of
all the elderly patients and that they are getting
different pills, different capsules instead of pills and
shapes and colours and sizes and names are all
changing.’ (GP3)
7. Reinforcement (increasing the probability of a response by arranging
a dependent relationship, or contingency, between the response and a
given stimulus)
Constructs
• Rewards (proximal/distal, valued/not valued, probable/
improbable)
• Incentives
• Punishment
• Consequents
• Reinforcement
• Contingencies
• Sanctions
✓ ‘I’m pretty sure it’s out there somewhere that it’s
the biggest source of litigation I think for GPs is
prescribing or … prescribing errors.’ (GP13)
‘The other thing I suppose is whether this
(educational training) will qualify for external CPD
points. Because we’re all required to get 20
external points and internal points …, and
certainly if it could be something that was worth
internal and external points, I think it could be
beneficial.’ (GP5)
8. Intentions (a conscious decision to perform a behaviour or a resolve
to act in a certain way)
Constructs
• Stability of intentions
• Stages of change model
• Transtheoretical model and stages of change
X ‘Sometimes it’s nearly easier to wait until the
outpatient’s letter come and then start the
medication.’ (GP7)
‘But if it was something like methotrexate … even
thinking about it now would give you the heebee
jeebees … you’ve somebody elderly in front of you
and you’re really not sure, I just don’t think you can
prescribe it really you know.’ (GP11)
9. Goals (mental representations of outcomes or end states that an
individual wants to achieve)
Constructs
• Goals (distal/proximal)
• Goal priority
• Goal/target setting
• Goals (autonomous/controlled)
• Action planning
• Implementation intention
X ‘I think we are all in it for the side of the patient like
what you want is a patient who’s prescribed
appropriate drugs, at an appropriate dose for
appropriate lengths of time.’ (GP10)
‘There are areas where I believe… for a pharmacist
within the clinical environment. And I think that
would work and certainly is one area we would love
to trial and have tried to do before. It works in
various areas in the UK. It’s been very successful.’
(GP3)
10. Memory, Attention and Decision Processes (the ability to retain
information, focus selectively on aspects of the environment and
choose between two or more alternatives)
Constructs
• Memory
• Attention
• Attention control
• Decision making
• Cognitive overload/tiredness
✓ ‘But if it was something like methotrexate … even
thinking about it now would give you the heebee
jeebees … you’ve somebody elderly in front of you
and you’re really not sure, I just don’t think you can
prescribe it really you know.’ (GP11)
‘ … if you do need to use something … bearing in
mind their cardiovascular risk, bearing in mind
their falls risk that go with lots of the sedative
medication, antipsychotics, sleeping tablets … I
think that’s my biggest bugbear, difficulty.’
(GP13)
11. Environmental Context and Resources (any circumstance of a
person’s situation or environment that discourages or encourages the
✓ ‘If you’re really busy sometimes and I’m just being
honest, you just print off their last month’s
(continues)
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compliance issues with their medicines by dispensing medi-
cines into weekly/monthly blister packs. Reviewing prescrip-
tions, checking drug doses and identifying potential drug
interactions and side-effects were other roles where pharma-
cists were identified as being a valuable support to the GP.
Most participants reported a good working relationship with
their local pharmacist.
‘We’re very lucky that we have a very good relationship with the
local pharmacist here they are very, very good and so we would
be on to them a numberof times a day… particularly for people
who come out from hospital whereas sometimes it isn’t clear
what dose of medications they’re on.’ (GP8)
Participants reported that GPs and pharmacists collabo-
rate successfully together on a regular basis. However, it was
suggested that the strengths of these existing relationships
between GPs and pharmacists were not harnessed to their full
potential. Maintaining and further enhancing the GP–
pharmacist relationship was viewed as an important strategy
to improve prescribing and patient care.
‘Pharmacists and doctors work very successfully together on a
daily routine basis, and that’s probably not recognized enough
but there is a significant interaction between the two. And any-
time there’s good positive interaction you’ll always get positive
responses and positive outputs.’ (GP3)
Table 2
(Continued)
Domain (definition) and constructs
Domain reported in
the study results Supporting quotes
development of skills and abilities, independence, social competence
and adaptive behaviour)
Constructs
• Environmental stressors
• Resources/material resources
• Organizational culture/climate
• Salient events/critical incidents
• Person × environment interaction
• Barriers and facilitators
prescription and you’ll keep going with that, you
know.’ (GP4)
‘We’re very lucky that we have a very good
relationship with the local pharmacist here they
are very, very good and so we would be on to them
a number of times a day … particularly for people
who come out from hospital whereas sometimes it
isn’t clear what dose of medications they’re on.’
(GP8)
12. Social influences (those interpersonal processes that can cause
individuals to change their thoughts, feelings or behaviours)
Constructs
• Social pressure/Social norms/Social comparisons
• Group conformity/Group norms/Group identity
• Social support
• Power
• Intergroup conflict
• Alienation
• Modelling
✓ ‘…so people do present saying I saw the ad on the
telly (for an anticholinergic medication for urinary
incontinence) and I have the overactive bladder
and you’re thinking anticholinergics and you’re 75
… but they still expect it you know.’ (GP1)
‘Any of those on the benzos you’d be trying to pull
them all off it ... Very hard, very hard. … And in
spite of you talking about the risk of falls and
obviously slowly weaning off … but very hard to
get patients off these tablets that are not essential
really you know.’ (GP7)
13. Emotion (a complex reaction pattern, involving experiential,
behavioural, and physiological elements, by which the individual
attempts to deal with a personally significant matter or event)
Constructs
• Fear
• Anxiety
• Affect
• Stress
• Depression
• Positive/negative affect
• Burn-out
X ‘I’m worried, I’m always worried about renal
function, I’m worried about anti-inflammatories
and hypertension, I’m worried about risk of
bleeding, I’m worried about side-effects, probably I
should worry more about drug interaction and I
don’t.’ (GP15)
‘But as regards other people highlighting it
(prescribing errors) I don’t mind, I’m just
embarrassed really.’ (GP11)
14. Behavioural Regulation (anything aimed at managing or changing
objectively observed or measured actions)
Constructs
• Self-monitoring
• Breaking habit
• Action planning
X ‘…you had a pharmacist coming in and doing an
audit on your over 65s every month, that they
came in and had access to your system. I think it
would be a great system.’ (GP7)
‘We have started actually about 4 or 5 months
ago, a repeat prescribing protocol within the
practice and as part of that we look at STOPP/
START.’ (GP15)
[STOPP/START: Screening Tool of Older Persons
Prescriptions/Screening Tool to Alert doctors to
Right Treatment criteria]
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Participants were asked to comment about the possibility
of a service-orientated outreach educational intervention
(such as academic detailing) provided by pharmacists to GPs
in their surgeries. Participants welcomed the idea of an educa-
tional intervention delivered to individual practices rather
than larger groups of GPs.
‘It would probably be better to have a practice do it in isolation
rather than two or three practices in the area doing it together.
Because I’m not sure that all practices would like to be open
with other practices about their prescribing. It’s kind of a per-
sonal thing isn’t it?’ (GP11)
Participants were asked about using information technol-
ogy systems such as clinical decision support systems to help
optimize their prescribing. They acknowledged that as pre-
scribing is a complicated process, especially in older people,
computerized systems would be of some benefit but only to
inform clinical situations and not to dictate them.
‘… prescribing is so complicated in the elderly I’m not sure if a
computer system could do it all. Now it might do a lot of it but
at the end of the day you are still going to have to make a deci-
sion on the patient sitting in front of you.’ (GP1)
Social influences
Participants reported that older patients can be influenced by
the marketing of medications in the lay media. This can in
turn influence patient requests and what GPs prescribe. For
example, anticholinergic medicines are indicated for urinary
incontinence, but GPs reported being reluctant to prescribe
them for older people due to their side-effects (i.e. falls, con-
fusion and blurred vision). However, despite these reserva-
tions, GPs felt pressurized into prescribing these medicines
due to patient expectations.
‘… so people do present saying I saw the ad on the telly (for an
anticholinergic medication for urinary incontinence) and I
have the overactive bladder and you’re thinking anticholiner-
gics and you’re 75 … but they still expect it you know.’ (GP1)
GPs experience difficulty in explaining why they are with-
holding such medications, particularly to an older person
with hearing, visual or cognitive impairment.
Stopping benzodiazepinemedicines was another example
of how patient preference conflicted with GPs’ knowledge
about the risks of the medication.
‘Any of those on the benzos you’d be trying to pull them all off
it ... Very hard, very hard. And … in spite of you talking about
the risk of falls and obviously slowly weaning off … but very
hard to get patients off these tablets that are not essential really
you know.’ (GP7)
Social/professional role and identity
Overall, the collaborative relationship between primary and
secondary care was described as very good. However, some
participants reported a lack of appreciation by their second-
ary care colleagues for their role as a GP. A lack of support
from secondary care was highlighted especially with the
management of complex patients in general practice.
‘I think some of the hospital sector, don’t fully understand the
nature of general practice … I saw a person with a renal prob-
lem and I was in their house … I rang the Urology (team) be-
cause they had a nephrostomy tube and they were asking me
what his creatinine was… they just had no idea that you don’t
have a portable creatinine monitor by your side.’ (GP8)
GPs described themselves as co-coordinators of care for
patients, which was assisted by their detailed medical record
for each of their patients.
‘As a GP you have a role as a co-ordinator of care, and you’d
have the most up to date record of everything that’s going on.’
(GP5)
Discussion
This study revealed the determinants influencing GP pre-
scribing behaviour for older adults in primary care and GPs’
views on potential intervention strategies to optimize pre-
scribing for older, often multi-morbid patients. A behaviour
change theory was used to analyse the data and generate find-
ings that could be used to inform intervention strategies.
The domain ‘Knowledge and Skills’ highlighted that the
responsibility of prescribing for increasing numbers of com-
plicated older patients was viewed as a burden for GPs. This
echoed the findings of a qualitative study of 20 practising
general internists and family practitioners in the United
States, which aimed to gain a deeper understanding of why
they found caring for older patients so challenging. Three
major domains emerged: medical complexity and chronicity
– for example, older people were seen to have more medical
conditions, prescribed more medicines, be more vulnerable
to illnesses and more susceptible to adverse drug reactions
(ADRs); personal and interpersonal challenges – e.g. hearing
problems, cognitive impairment and family members caring
for these patients; and administrative burden – e.g. time con-
suming, increased workload, risk of litigation. Contextual
conditions such as the practice environment and the GPs’
training and personal values also influenced the care for these
patients [26].
From the domain ‘Environmental Context and Re-
sources’, lack of available time for GPs was cited as a major
barrier during clinical practice. As a result, GPs were unable
to carry out all their clinical roles (e.g., review patient’s
monthly prescriptions upon renewal). Braddock et al. argue
that the issue of time has an ethical significance as it may re-
sult in GPs sacrificing duties that promote important features
of the patient–GP relationship such as trust, respect and fidel-
ity, act as a barrier to shared decision making and being un-
able to fulfil their obligations as patient advocates [27].
Pharmacists were described as a reliable resource for GPs
andmany participants reported experiencing a good working
relationship with their local pharmacist. In a qualitative
study with 27 GPs and 31 pharmacists in the UK, GPs re-
ported that knowing the pharmacist was an essential
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component of a successful GP–pharmacist collaboration.
This professional familiarity was also considered an impor-
tant factor in the provision of local pharmaceutical services
pilots. Pharmacists experienced difficulty working in collabo-
ration with large GP surgeries. GPs who were reluctant to col-
laborate expressed concerns about the standard of
pharmacists’ qualifications and therefore questioned their
professional ability. Collaboration between both HCPs was
optimized with reciprocal communication. Conversely, one-
way communication was associated with lower levels of col-
laboration [28].
Implications for research and/or practice
Computerized decision support systems are widely used tools
that optimize quality of care and patient outcomes [29]. In
practice, these systemsmay involve an alert system appearing
at the end of a consultation or at the time of prescribing [30–
32]. Participants in our study agreed that computerized deci-
sion support systems could be a useful resource for GP pre-
scribing; however, some were concerned they may dictate
rather than inform a clinical situation. In order for successful
implementation of decision support systems in GP practices,
software designers should consider the following: the system
should be incorporated into the practice workflow and
existing computerized systems, involve all stakeholders dur-
ing various stages of the implementation process, and ensure
alerts are straightforward and easy to understand [33].
This study found that GPs feel they will need additional
training in pharmacology and drug interactions as the older
population increases. Prescribing for older people is a
complex process and GPs welcomed supportive strategies to
optimize the continuing care for this group of patients. One
possible solution to optimize prescribing for this growing
cohort of older patients prescribed multiple medications is
academic detailing (AD). Academic detailers, who are usually
pharmacists, nurses or doctors, are trained to provide
accurate, objective and up-to-date synthesis of the best
available information on a clinical topic in an engaging
format with GPs [34]. This information often includes
recommendations about alternative treatment regimens or
non-pharmacological interventions [35]. A pharmacist-led
intervention comprising AD demonstrated an improvement
in statin prescribing in high-risk patients in primary care
in the UK [36]. A study in the United States found that
two brief AD visits by clinical pharmacists to GPs reduced
inappropriate prescribing by 14% in comparison with
controls [37].
While clinical decision support systems and AD have
been adopted in other countries, these strategies are not rou-
tinely available in Irish general practice.
A large body of research has been carried out on the role of
pharmacists in optimizing GP prescribing in primary care.
However, much of this work shows limited or inconsistent re-
sults. A Cochrane review examined the evidence for
pharmacist-led interventions aimed at improving appropri-
ate polypharmacy for older people across different healthcare
settings. The authors concluded, based on the 12 studies in-
cluded in the review, that it was unclear whether the inter-
ventions led to clinically significant improvements [38].
Another systematic review focused on the effect of
pharmacist-led interventions in optimizing prescribing in
older adults in primary care. Although it appeared that these
interventions improved prescribing appropriateness, it was
unclear if they resulted in clinically significant improve-
ments in patient outcomes [39].
Despite these limited effects, our qualitative study shows
that GPs still view the role of pharmacists and their own rela-
tionship with pharmacists in a positive way. It highlights that
there is scope to harness the GP–pharmacist relationship to
improve patient outcomes, and supports a need for interven-
tion developers to consider other approaches to enhance the
GP–pharmacist relationship in a way that will lead to mean-
ingful and sustained improvements in prescribing.
Strengths and limitations
The findings of this study are underpinned by a theoretical
model that was specifically designed for analysing HCPs’ be-
haviour, and thus offers a number of strengths [19, 40]. The
TDF facilitates comprehensive assessment of the possible in-
fluences on behaviour and lends clarity to these influences
by characterizing each domain with component constructs
[19]. However, the TDF is a relatively new framework and is
still undergoing refinement. We suggest that future iterations
of this framework may recognize the similarity between some
domains in certain contexts such as ‘Knowledge’ and ‘Skills’
for cognitive tasks such as prescribing.
Prolonged engagement with the data was carried out as
interviews were arranged with GPs over a five-month period,
and were analysed on an iterative basis. The method devel-
oped by Francis et al. was used systematically to determine
data saturation [22]. Data triangulation was not conducted
in this study as there was only one group of research partici-
pants. As GPs are the main prescribers of medication in pri-
mary care, they were identified as the key participants to
answer the study question. Also one means of data collection
was used, namely semi-structured interviews. This interview
method was chosen as it has the ability to achieve compre-
hensive coverage of the topic discussed. The validation tech-
nique of member checking was not used [41], as returning
interview transcripts to participants can lead to changes be-
ing made to the transcripts which can influence the trustwor-
thiness of any subsequent analysis.
The transferability of the data may be limited by sam-
pling GPs from one geographical region in Ireland. How-
ever, the broad inclusion criteria (requirement to be in
active practice) and the recruitment of GPs with a range
of years of experience, gender, practice size and
urban/rural locations helps ensure that our findings reflect
the most important factors that influence GP prescribing
for older people in Ireland.
Although data collection was only carried out by one
researcher (D.O.R.), dependability was enhanced by using
multidisciplinary team input – pharmacists (D.O.R., S.B.,
A.F.), GP (C.S.), physiotherapist (R.G.) and epidemiologist
(P.K.) – during data analysis (investigator triangulation).
Additionally, D.O.R. maintained a reflexive diary about his
role and beliefs on the study topic during the course of
the interviews and discussed this with other members of
the team to help highlight any personal biases or chal-
lenges encountered.
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Conclusion
This study has identified the key determinants that influence
GP prescribing behaviour for older people in primary care.
GPs are aware that prescribing for older people is a complex
process that requires an increasing amount of their time and
attention. GPs state that they require accurate, easily accessi-
ble sources of evidence-based data about the effectiveness
and safety of treatments to support their prescribing for older,
complex patients. Future interventions should incorporate
means of providing such information, for example academic
detailing (AD), to ensure that GPs are provided with necessary
evidence and are equipped with the necessary skills to pre-
scribe safely for the growing cohort of older, complex
patients.
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